In line with this concept, we have previously shown that SREBP-1-mediated lipogenesis plays a critical role in maintaining therapy resistance in BRAF mutant melanoma and that SREBP-1 inhibition elevates lipid peroxidation, exerting a cytostatic effect [10]. This evidence concerns the gene SREBF1 and melanoma.